SACRAMENTO, Calif., April 13, 2018 -- The upcoming launch of the U.S. Air Force Space Command (AFSPC)-11 satellite aboard a United Launch Alliance Atlas V rocket from Cape Canaveral Air Force Station, Florida, will benefit from just over 1.74 million pounds of added thrust from five AJ-60A solid rocket boosters supplied by Aerojet Rocketdyne. The mission marks the eighth flight of the Atlas V 551 configuration, the most powerful Atlas V variant that has flown to date.
The Atlas V 551 configuration features a 5-meter payload fairing, five AJ-60As and a Centaur upper stage powered by a single Aerojet Rocket RL10C-1 engine. This configuration of the U.S. government workhorse launch vehicle is capable of delivering 8,900 kilograms of payload to geostationary transfer orbit (GTO), and also has been used to send scientific probes to explore Jupiter and Pluto. The Centaur upper stage also uses smaller Aerojet Rocketdyne thrusters for pitch, yaw and roll control, while both stages of the Atlas V employ pressurization vessels built by Aerojet Rocketdyne's ARDÉ subsidiary.
“The Atlas V is able to perform a wide variety of missions for both government and commercial customers, and the AJ-60A is a major factor in that versatility,” said Aerojet Rocketdyne CEO and President Eileen Drake. “Aerojet Rocketdyne developed the AJ-60A specifically for the Atlas V, delivering the first booster just 42 months after the contract award, which underscores our team’s ability to design and deliver large solid rocket motors in support of our nation’s strategic goals and efforts to explore our solar system.”
The flight of the 100th AJ-60A, the largest monolithically wound solid rocket booster ever flown, took place recently as part of a complement of four that helped an Atlas V 541 place the nation’s newest weather satellite into GTO. Anywhere from one to five AJ-60As, each generating 348,500 pounds of thrust, can be used to augment the lift capability of the Atlas V, which has flown 76 missions to date in all of its configurations.
AFSPC-11 is a multi-manifested mission. The forward spacecraft is referred to as CBAS (Continuous Broadcast Augmenting SATCOM) and the aft spacecraft is EAGLE (ESPA Augmented GEO Laboratory Experiment).
Aerojet Rocketdyne, a subsidiary of Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD), is an innovative company delivering solutions that create value for its customers in the aerospace and defense markets. The company is a world-recognized aerospace and defense leader that provides propulsion and energetics to the space, missile defense and strategic systems, tactical systems and armaments areas, in support of domestic and international markets. Additional information about Aerojet Rocketdyne can be obtained by visiting our websites at www.Rocket.com and www.AerojetRocketdyne.com.
Contact: Todd McConnell, Aerojet Rocketdyne, 561-882-5395
[email protected]
Mary Engola, Aerojet Rocketdyne, 571-289-1371
[email protected]


Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
FTC Questions Apple News Over Alleged Bias Against Conservative Media
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 



